IPEC likes what China's doing with excipients; Ranbaxy reports surprise loss;

> A 140% surge in North American sales, driven by its generic Lipitor, was not enough to keep Ranbaxy Laboratories from reporting a quarterly loss. Story

> Uganda has banned 67 drugs from Indian maker Flamingo, claiming that they are substandard. Story

> CVS Caremark ($CVS) realized an 18.4% earnings jump in the last quarter, having grabbed business during the Walgreen ($WAG), Express Scripts ($ESRX) fight. Story

> New guidelines from China's State Food and Drug Administration (SFDA) for excipients has impressed The International Pharmaceutical Excipients Council (IPEC) Americas, which says they are consistent with its own guidelines. Story

And Finally... University of Central Florida scientists think they have stumbled upon a simpler and more efficient way to mass produce the structured nanoparticles used for drug delivery and production. Story


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.